Cargando…
Identification of COX5B as a novel biomarker in high-grade glioma patients
BACKGROUND: Malignant glioma is the second leading cause of cancer-related death worldwide, and is known to exhibit a high degree of heterogeneity in its deregulation of different oncogenic pathways. The molecular subclasses of human glioma are not well known. Thus, it is crucial to identify vital o...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695267/ https://www.ncbi.nlm.nih.gov/pubmed/29180880 http://dx.doi.org/10.2147/OTT.S139243 |